Genome-wide screening for methylation-silenced genes in colorectal cancer

Khamas,Ahmed; Ishikawa,Toshiaki; Mogushi,Kaoru; Iida,Satoru; Ishiguro,Megumi; Tanaka,Hiroshi; Uetake,Hiroyuki; Sugihara,Kenichi

doi:10.3892/ijo.2012.1500

Genome-wide screening for methylation-silenced genes in colorectal cancer

Authors:
- Ahmed Khamas
- Toshiaki Ishikawa
- Kaoru Mogushi
- Satoru Iida
- Megumi Ishiguro
- Hiroshi Tanaka
- Hiroyuki Uetake
- Kenichi Sugihara
View Affiliations

Affiliations: Department of Surgical Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan, Department of Computational Biology, Graduate School of Biomedical Science, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan, Department of Translational Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
Published online on: May 30, 2012 https://doi.org/10.3892/ijo.2012.1500
Pages: 490-496

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Identification of methylation-silenced genes in colorectal cancer (CRC) is of great importance. We employed oligonucleotide microarrays to identify differences in global gene expression of five CRC cell lines (HCT116, RKO, Colo320, SW480 and HT29) that were analyzed before and after treatment with 5-aza-2'-deoxycitidine. Selected candidates were subjected to methylation-specific PCR and real-time quantitative reverse transcription-PCR using 15 CRC cell lines and 23 paired tumor and normal samples from CRC patients. After 5-aza-2'-deoxycitidine treatment, 139 genes were re-expressed in all 5 CRC cell lines collectively with a fold change of more than 1.5 in at least one cell line. These genes include known methylated and silenced genes in CRC. After applying study selection criteria we identified 20 candidates. The GADD45B and THSD1 genes were selected for further analysis. Among 15 colon cancer cell lines, methylation was only identified in THSD1 (27%). THSD1 methylation was subsequently investigated in 23 colorectal tumors and methylation was detected in 9% of the analyzed samples; the observed promoter hypermethylation was cancer-specific. THSD1 mRNA down-regulation was observed in tumor tissues. This genome-wide screening led to the identification of genes putatively affected by methylation in CRC. The THSD1 gene may play a role in the tumorigenesis of CRC.

View Figures

View References

1	Jones PA and Laird PW: Cancer epigenetics comes of age. Nat Genet. 21:163–167. 1999. View Article : Google Scholar : PubMed/NCBI
2	Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar : PubMed/NCBI
3	Esteller M: Dormant hypermethylated tumour suppressor genes: questions and answers. J Pathol. 205:172–180. 2005. View Article : Google Scholar : PubMed/NCBI
4	Karpf AR and Jones DA: Reactivating the expression of methylation silenced genes in human cancer. Oncogene. 21:5496–5503. 2002. View Article : Google Scholar : PubMed/NCBI
5	Yamashita K, Upadhyay S, Osada M, et al: Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell. 2:485–495. 2002. View Article : Google Scholar : PubMed/NCBI
6	Suzuki H, Gabrielson E, Chen W, et al: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 31:141–149. 2002. View Article : Google Scholar : PubMed/NCBI
7	Koul S, Houldsworth J, Mansukhani MM, et al: Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol Cancer. 1:82002. View Article : Google Scholar : PubMed/NCBI
8	Konduri SD, Srivenugopal KS, Yanamandra N, et al: Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene. 22:4509–4516. 2003. View Article : Google Scholar : PubMed/NCBI
9	Knobbe CB, Reifenberger J, Blaschke B and Reifenberger G: Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. J Natl Cancer Inst. 96:483–486. 2004. View Article : Google Scholar
10	Sawa H, Murakami H, Ohshima Y, et al: Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol. 19:77–81. 2002. View Article : Google Scholar : PubMed/NCBI
11	Schuebel KE, Chen W, Cope L, et al: Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 3:1709–1723. 2007. View Article : Google Scholar : PubMed/NCBI
12	Ishiguro M, Iida S, Uetake H, et al: Effect of combined therapy with low-dose 5-aza-2′-deoxycytidine and irinotecan on colon cancer cell line HCT-15. Ann Surg Oncol. 14:1752–1762. 2007.
13	Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
14	Qiu W, Zhou B, Zou H, et al: Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. Am J Pathol. 165:1689–1699. 2004. View Article : Google Scholar : PubMed/NCBI
15	Ko JM, Chan PL, Yau WL, et al: Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol Cancer Res. 6:592–603. 2008. View Article : Google Scholar : PubMed/NCBI
16	Mori Y, Yin J, Sato F, et al: Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning. Cancer Res. 64:2434–2438. 2004. View Article : Google Scholar
17	Khamas A, Ishikawa T, Shimokawa K, et al: Screening for epigenetically masked genes in colorectal cancer using 5-aza-2′-deoxycytidine, microarray and gene expression profile. Cancer Genomics Proteomics. 9:67–75. 2012.PubMed/NCBI
18	Liang G, Gonzales FA, Jones PA, Orntoft TF and Thykjaer T: Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res. 62:961–966. 2002.PubMed/NCBI
19	Huang DW, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
20	Ali D: Identification of novel epigenetic biomarkers in colorectal cancer, GLDC and PPP1R14A. Department of Molecular Biosciences (IMBV), Faculty of Mathematics and Natural Sciences, University of Oslo; pp. 972010
21	Easwaran HP, van Neste L, Cope L, et al: Aberrant silencing of cancer-related genes by CpG hypermethylation occurs independently of their spatial organization in the nucleus. Cancer Res. 70:8015–8024. 2010. View Article : Google Scholar : PubMed/NCBI
22	Kim MS, Lee J and Sidransky D: DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 29:181–206. 2010. View Article : Google Scholar : PubMed/NCBI
23	Xu L and Jain RK: Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma. Mol Cancer Res. 5:873–880. 2007. View Article : Google Scholar : PubMed/NCBI
24	Gardiner-Garden M and Frommer M: CpG islands in vertebrate genomes. J Mol Biol. 196:261–282. 1987. View Article : Google Scholar : PubMed/NCBI
25	Takai D and Jones PA: The CpG island searcher: a new WWW resource. In Silico Biol. 3:235–240. 2003.PubMed/NCBI
26	Karolchik D, Hinrichs AS, Furey TS, et al: The UCSC table browser data retrieval tool. Nucleic Acids Res. 32:D493–D496. 2004. View Article : Google Scholar : PubMed/NCBI
27	Lind GE, Thorstensen L, Løvig T, et al: A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer. 3:282004. View Article : Google Scholar : PubMed/NCBI
28	Zhang X and Lawler J: Thrombospondin-based antiangiogenic therapy. Microvasc Res. 74:90–99. 2007. View Article : Google Scholar : PubMed/NCBI
29	Rojas A, Meherem S, Kim YH, et al: The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Int J Cancer. 123:14–21. 2008.
30	Moncada-Pazos A, Obaya AJ, Fraga MF, et al: The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci. 122:2906–2913. 2009.
31	Lai PS, Cheah PY, Kadam P, et al: Overexpression of RB1 transcript is significantly correlated with 13q14 allelic imbalance in colorectal carcinomas. Int J Cancer. 119:1061–1066. 2006.PubMed/NCBI
32	Derks S, Postma C, Carvalho B, et al: Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis. 29:434–439. 2008. View Article : Google Scholar
33	Kis E, Szatmári T, Keszei M, et al: Microarray analysis of radiation response genes in primary human fibroblasts. Int J Radiat Oncol Biol Phys. 66:1506–1514. 2006. View Article : Google Scholar : PubMed/NCBI
34	Kazerounian S, Yee KO and Lawler J: Thrombospondins in cancer. Cell Mol Life Sci. 65:700–712. 2008. View Article : Google Scholar : PubMed/NCBI
35	Lagerstedt KK, Kristiansson E, Lönnroth C, et al: Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients. Cancer Inform. 9:79–91. 2010.PubMed/NCBI
36	Cretu A, Sha X, Tront J, Hoffman B and Liebermann DA: Stress sensor Gadd45 genes as therapeutic targets in cancer. Cancer Ther. 7:268–276. 2009.PubMed/NCBI
37	Ying J, Srivastava G, Hsieh WS, et al: The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res. 11:6442–6449. 2005.
38	Ju S, Zhu Y, Liu L, et al: Gadd45b and Gadd45g are important for anti-tumor immune responses. Eur J Immunol. 39:3010–3018. 2009. View Article : Google Scholar : PubMed/NCBI
39	Na YK, Lee SM, Hong HS, Kim JB, Park JY and Kim DS: Hypermethylation of growth arrest DNA-damage-inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features. Mol Cells. 30:89–92. 2010. View Article : Google Scholar : PubMed/NCBI